All lobbying filings

GRV Strategies LLC

GRV Strategies LLC filed a Q3 report for Eli Lilly and Company on October 9, 2025, reporting $60,000 in lobbying income.

Lobbying for Eli Lilly and Company · Biopharmaceutical company

As filed: GRV STRATEGIES LLC for ELI LILLY AND COMPANY.

All filings by GRV Strategies LLC · Everything Eli Lilly and Company has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 9, 2025

Income

$60,000

What the client paid this registrant for the period.

Client based in

Indiana

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Issues related to healthcare

Trade (domestic/foreign)

Issues related to trade

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem